Henen, Morkos A. published the artcile[1,2,4]Triazolo[4,3-a]quinoxaline: synthesis, antiviral, and antimicrobial activities, Quality Control of 39267-05-5, the main research area is triazoloquinoxaline bioisostere pyrimidotriazoloquinoxaline preparation antibacterial antifungal antiviral agent.
Several novel [1,2,4]triazolo[4,3-a]quinoxaline derivatives and their isosteres, pyrimidine-quinoxaline derivatives [i.e., Pyrimido[1′,2′:1,5][1,2,4]triazolo[4,3-a]quinoxaline derivatives] were designed as potential antiviral and antimicrobial agents and the synthesis of the target compounds was achieved using 4-chloro-8-methyl[1,2,4]triazolo[4,3-a]quinoxalin-1-amine as a key intermediate in an an aromatic nucleophilic substitution with different amines or triazolethiol. Some of the title compounds were subjected to an in-vitro antiviral and cytotoxicity screening by a plaque-reduction assay method. Most of the tested compounds exhibited cytotoxicity at a concentration 160 μg/mL and one compound displayed promising antiviral activity. In-vitro antimicrobial screening against different pathogenic organisms using an agar diffusion method demonstrated that several compounds also exhibited antibacterial and/or antifungal activities.
Medicinal Chemistry Research published new progress about Anti-infective agents. 39267-05-5 belongs to class quinoxaline, name is 2,3-Dichloro-6-methylquinoxaline, and the molecular formula is C9H6Cl2N2, Quality Control of 39267-05-5.
Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider